Table 3.
Susceptibility profile of Escherichia coli n=78 | |||
---|---|---|---|
ESBL n= 27 (34.6%) |
n° (%) | non-ESBL n= 51 (65.4%) |
n° (%) |
ESBL + | 17 (63.0) | Susceptible | 44 (86.3) |
ESBL + GEMR | 2 (7.4) | AMKI | 2 (3.9) |
ESBL + NALR | 2 (7.4) | CIPI | 2 (3.9) |
ESBL + AMKR | 1 (3.7) | NALI | 1(2.0) |
ESBL + NALR + CIPR | 1 (3.7) | NALR | 1(2.0) |
ESBL + AMKR + GEMR | 1 (3.7) | NALI + CIPI | 1(2.0) |
ESBL + AMKR + GEMR + CIPR | 3 (11.1) | ||
Total | 27 (100) | Total | 51 (100) |
AMK: amikacin; CIP: ciprofloxacin; R: resistant; I: intermediate susceptibility; ESBL: extended-spectrum-β-lactamase; GEM: gentamicin; NAL: nalidixic acid;